Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
12.18
+0.10 (0.83%)
Dec 20, 2024, 4:00 PM EST - Market closed
Intellia Therapeutics Market Cap
Intellia Therapeutics has a market cap or net worth of $1.24 billion as of December 20, 2024. Its market cap has decreased by -53.48% in one year.
Market Cap
1.24B
Enterprise Value
397.46M
1-Year Change
-53.48%
Ranking
Category
Stock Price
$12.18
Market Cap Chart
Since May 6, 2016, Intellia Therapeutics's market cap has increased from $757.50M to $1.24B, an increase of 63.76%. That is a compound annual growth rate of 5.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 1.24B | -54.57% |
| Dec 29, 2023 | 2.73B | -0.54% |
| Dec 30, 2022 | 2.75B | -68.80% |
| Dec 31, 2021 | 8.80B | 173.78% |
| Dec 31, 2020 | 3.21B | 348.19% |
| Dec 31, 2019 | 717.10M | 20.99% |
| Dec 31, 2018 | 592.70M | -14.55% |
| Dec 29, 2017 | 693.60M | 46.98% |
| Dec 30, 2016 | 471.90M | -37.70% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evolent Health | 1.29B |
| AdaptHealth | 1.28B |
| Day One Biopharmaceuticals | 1.26B |
| Alphatec Holdings | 1.25B |
| STAAR Surgical Company | 1.23B |
| Harrow | 1.23B |
| Arvinas | 1.23B |
| BioLife Solutions | 1.21B |